630 related articles for article (PubMed ID: 26751902)
1. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
3. Personalized medicine into health national services: barriers and potentialities.
Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
[TBL] [Abstract][Full Text] [Related]
4. The role of pharmacogenetics and pharmacogenomics in 21st-century medicine: state of the art and new challenges discussed in the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society (SEFF).
Rodriguez-Antona C
Drug Metab Pers Ther; 2016 Mar; 31(1):1-2. PubMed ID: 26641977
[No Abstract] [Full Text] [Related]
5. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
[TBL] [Abstract][Full Text] [Related]
6. The future of research into genetics and the precision dosing of tacrolimus: what do we need to know?
Zhu J; Pasternak AL; Crona DJ
Pharmacogenomics; 2020 Oct; 21(15):1061-1064. PubMed ID: 32896220
[No Abstract] [Full Text] [Related]
7. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
Lazaridis KN
Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
[TBL] [Abstract][Full Text] [Related]
8. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
9. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
Becquemont L; Alfirevic A; Amstutz U; Brauch H; Jacqz-Aigrain E; Laurent-Puig P; Molina MA; Niemi M; Schwab M; Somogyi AA; Thervet E; Maitland-van der Zee AH; van Kuilenburg AB; van Schaik RH; Verstuyft C; Wadelius M; Daly AK
Pharmacogenomics; 2011 Jan; 12(1):113-24. PubMed ID: 21174626
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
Tavakolpour S; Darvishi M; Ghasemiadl M
Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics and immunosuppressive drugs.
Hronová K; Šíma M; Světlík S; Matoušková O; Slanař O
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):821-35. PubMed ID: 25301406
[TBL] [Abstract][Full Text] [Related]
12. Human genetics: international projects and personalized medicine.
Apellaniz-Ruiz M; Gallego C; Ruiz-Pinto S; Carracedo A; Rodríguez-Antona C
Drug Metab Pers Ther; 2016 Mar; 31(1):3-8. PubMed ID: 26581075
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics in the clinic.
Relling MV; Evans WE
Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
15. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy.
Stojiljkovic M; Fazlagic A; Dokmanovic-Krivokapic L; Nikcevic G; Patrinos GP; Pavlovic S; Zukic B
Hum Genomics; 2012 Sep; 6(1):19. PubMed ID: 23157848
[TBL] [Abstract][Full Text] [Related]
16. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
17. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
Ciarleglio AE; Ma C
Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
[TBL] [Abstract][Full Text] [Related]
18. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
[TBL] [Abstract][Full Text] [Related]
19. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
Hess GP; Fonseca E; Scott R; Fagerness J
Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
